161 related articles for article (PubMed ID: 36721917)
1. Associations between maternal depressive symptoms and selective serotonin reuptake inhibitor antidepressant treatment on internalising and anxiety behaviours in children: 12-year longitudinal study.
Hutchison SM; Brain U; Grunau RE; Kuzeljevic B; Irvine M; Mâsse LC; Oberlander TF
BJPsych Open; 2023 Feb; 9(2):e26. PubMed ID: 36721917
[TBL] [Abstract][Full Text] [Related]
2. Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age.
Oberlander TF; Papsdorf M; Brain UM; Misri S; Ross C; Grunau RE
Arch Pediatr Adolesc Med; 2010 May; 164(5):444-51. PubMed ID: 20439795
[TBL] [Abstract][Full Text] [Related]
3. Impact of Prenatal Selective Serotonin Reuptake Inhibitor Antidepressant Exposure and Maternal Mood on Physical Activity, Dietary Intake, and Markers of Adiposity at Age 6 Years.
Hutchison SM; Mâsse LC; Glier MB; Brain U; Devlin AM; Oberlander TF
J Dev Behav Pediatr; 2019 May; 40(4):266-274. PubMed ID: 30950906
[TBL] [Abstract][Full Text] [Related]
4. Effects of maternal depression and prenatal SSRI exposure on executive functions and susceptibility to household chaos in 6-year-old children: prospective cohort study.
Dhaliwal G; Weikum WM; Jolicoeur-Martineau A; Brain U; Grunau RE; Oberlander TF
BJPsych Open; 2020 Sep; 6(5):e106. PubMed ID: 32892791
[TBL] [Abstract][Full Text] [Related]
5. A 6-year longitudinal study: Are maternal depressive symptoms and Selective Serotonin Reuptake Inhibitor (SSRI) antidepressant treatment during pregnancy associated with everyday measures of executive function in young children?
Hutchison SM; Mâsse LC; Brain U; Oberlander TF
Early Hum Dev; 2019 Jan; 128():21-26. PubMed ID: 30447406
[TBL] [Abstract][Full Text] [Related]
6. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.
Pawluski JL; Galea LA; Brain U; Papsdorf M; Oberlander TF
Pediatrics; 2009 Oct; 124(4):e662-70. PubMed ID: 19786426
[TBL] [Abstract][Full Text] [Related]
7. Perinatal selective serotonin reuptake inhibitor (SSRI) and other antidepressant exposure effects on anxiety and depressive behaviors in offspring: A review of findings in humans and rodent models.
Hutchison SM; Mâsse LC; Pawluski JL; Oberlander TF
Reprod Toxicol; 2021 Jan; 99():80-95. PubMed ID: 33253794
[TBL] [Abstract][Full Text] [Related]
8. Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy.
Oberlander TF; Reebye P; Misri S; Papsdorf M; Kim J; Grunau RE
Arch Pediatr Adolesc Med; 2007 Jan; 161(1):22-9. PubMed ID: 17199063
[TBL] [Abstract][Full Text] [Related]
9. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
Rotem-Kohavi N; Williams LJ; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808
[TBL] [Abstract][Full Text] [Related]
10. Prenatal Selective Serotonin Reuptake Inhibitor Exposure, Depression, and Brain Morphology in Middle Childhood: Results From the ABCD Study.
Moreau AL; Voss M; Hansen I; Paul SE; Barch DM; Rogers CE; Bogdan R
Biol Psychiatry Glob Open Sci; 2023 Apr; 3(2):243-254. PubMed ID: 37124359
[TBL] [Abstract][Full Text] [Related]
11. Variations in Neurodevelopmental Outcomes in Children with Prenatal SSRI Antidepressant Exposure.
Rotem-Kohavi N; Oberlander TF
Birth Defects Res; 2017 Jul; 109(12):909-923. PubMed ID: 28714603
[TBL] [Abstract][Full Text] [Related]
12. Intra-uterine exposure to selective serotonin reuptake inhibitors (SSRIs), maternal psychopathology, and neurodevelopment at age 2.5years - Results from the prospective cohort SMOK study.
van der Veere CN; de Vries NKS; van Braeckel KNJA; Bos AF
Early Hum Dev; 2020 Aug; 147():105075. PubMed ID: 32504880
[TBL] [Abstract][Full Text] [Related]
13. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
[TBL] [Abstract][Full Text] [Related]
14. Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: effects on the infant.
Nordeng H; Spigset O
Drug Saf; 2005; 28(7):565-81. PubMed ID: 15963005
[TBL] [Abstract][Full Text] [Related]
15. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.
Oberlander TF; Grunau RE; Fitzgerald C; Papsdorf M; Rurak D; Riggs W
Pediatrics; 2005 Feb; 115(2):411-25. PubMed ID: 15687451
[TBL] [Abstract][Full Text] [Related]
16. Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications.
Misri S; Reebye P; Kendrick K; Carter D; Ryan D; Grunau RE; Oberlander TF
Am J Psychiatry; 2006 Jun; 163(6):1026-32. PubMed ID: 16741203
[TBL] [Abstract][Full Text] [Related]
17. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
Singal D; Brownell M; Chateau D; Ruth C; Katz LY
BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
[TBL] [Abstract][Full Text] [Related]
18. Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study.
Lupattelli A; Mahic M; Handal M; Ystrom E; Reichborn-Kjennerud T; Nordeng H
BJOG; 2021 Nov; 128(12):1917-1927. PubMed ID: 33982858
[TBL] [Abstract][Full Text] [Related]
19. Prenatal antidepressant exposure and emotional disorders until age 22: a danish register study.
Bliddal M; Wesselhoeft R; Strandberg-Larsen K; Ernst MT; Weissman MM; Gingrich JA; Talati A; Pottegård A
Child Adolesc Psychiatry Ment Health; 2023 Jun; 17(1):73. PubMed ID: 37328889
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
